克里斯普尔/卡斯系统:一种强大的策略,以改善人类单一性疾病作为治疗交付;当前的应用和挑战
Fatemeh Saberi1, Zeinab Yousefi-Najafabadi2,3, Forough Shams1,4
1Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, 1968917313, Tehran, Iran.
Current gene therapy
|January 9, 2025
概括
像CRISPR这样的基因编辑技术为单基因疾病提供了有效的治疗方法,单基因突变引起的遗传性疾病. 本综述探讨了针对这些疾病的基于CRISPR的基因疗法的最新进展.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 单一性疾病是由单个基因突变引起的遗传性疾病,通常在儿童期表现出来,导致显著的发病率或死亡率.
- 自1989年以来使用的基因疗法为单一性疾病提供了一种有效和有针对性的治疗方法.
- 基因编辑技术,特别是基于CRISPR的系统,显示出修复这些疾病背后的基因突变的希望.
研究的目的:
- 提供基于CRISPR的基因编辑对单一性疾病的近期治疗应用的概述.
- 巩固推进单基因疾病基因疗法选择的战略.
- 作为未来研究和治疗单一性疾病的临床应用的参考.
主要方法:
- 对基于CRISPR的基因编辑应用在单一性疾病中的当前文献的综述.
- 在体内和体外治疗模型的分析.
- 巩固各种基因治疗策略.
主要成果:
- 基于CRISPR的基因编辑是单一性疾病的ex vivo和in vivo治疗的关键技术.
- 最近的进展凸显了CRISPR在各种单一性疾病中修复基因突变的潜力.
- 该审查巩固了新基因疗法开发的各种策略.
结论:
- 基于CRISPR的基因编辑代表了单一性疾病治疗领域的重大进步.
- 这些基因编辑工具的进一步研究和应用可以为患者改善治疗选择.
- 本综述为基因治疗遗传性疾病的持续发展提供了宝贵的资源.
更多相关视频
09:00Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
8.1K
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
7.7K
相关概念视频
01:59CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
02:53CRISPR and crRNAs
16.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.6K
00:49What is Genetic Engineering?
73.5K
Overview
73.5K
02:31Homologous Recombination
50.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.1K